Implantable isoxazoline pharmaceutical compositions and uses thereof
An implant for the control of parasites in livestock comprising an isoxazoline compound of Formula (I) or salt or solvate thereof, wherein the implant comprises one or more pellets each of which comprises the isoxaxoline compound and a pharmaceutically acceptable excipient and a method of preventing or treating a parasite infestation using the same.
1. An implant for the control of parasites in livestock comprising fluralaner or salt or solvate thereof, wherein the implant comprises one or more immediate release pellets and one or more delayed release pellets wherein the ratio of the immediate release pellets and the delayed release pellets is between 1:10 and 10:1 and wherein
a) the immediate release pellets comprise
i) fluralaner
ii) diluent
iii) binder and
iv) micronized intragranular poloxamer, and
b) the delayed release pellets comprise
i) fluralaner
ii) diluent
iii) binder
wherein the delayed release pellets are coated with a biodegradable polymer.
2. The implant of claim 1 , wherein the diluent is lactose.
3. The implant of claim 1 , wherein the binder is povidone.
4. The implant of claim 1 , wherein the percentage of fluralaner in each pellet is between about 50% w/w to about 90% w/w.
5. The implant of claim 1 , wherein the ratio of the immediate release pellets to delayed release pellets is about 1:1.
6. The implant of claim 1 , wherein the biodegradable polymer is chosen from poly(lactic-co-glycolic acid) (PLGA) and polycaprolactone (PCL).
7. The implant of claim 6 , wherein the biodegradable polymer is poly(lactic-co-glycolic acid) (PLGA) and the ratio of the lactic acid and glycolic acid monomers in the PLGA is about 50:50 to about 90:10.
8. The implant of claim 7 , wherein the delayed release pellets are coated with PLGA 65:35.